Bringing transparency to scientific publishing and to research ethics

Printer-friendly versionPDF version
Michele Garfinkel
European Molecular Biology Organization (EMBO)
Wednesday, 2 March 2016 - 12:00

Scientific publishing and the ways scientists use the scientific literature are changing rapidly. Obvious examples of this are the move away from print publication, and moves toward open access to text and data. But other changes in publishing are occurring as a result of the development of new ideas in science governance; in turn, some of these changes alter the way scientists and administrators look at governance. In this talk, I will review some of these developments particularly with respect to research assessment, responsible conduct of research, and the value of transparency in science. I will use some examples directly from the journals of the EMBO Press and will include a more general discussion about immediate policy concerns.

Place: 

Ciudad Politécnica de la Innovación
Edificio 8E, Acceso J, Planta 3ª (Salón de Actos. Cubo Rojo)
Universidad Politécnica de Valencia | Camino de Vera s/n

Short CV: 

Michele Garfinkel is the Manager of the Science Policy Programme at EMBO (European Molecular Biology Organization) in Heidelberg, Germany. She is responsible for policy research on issues in emerging technologies, scientific publishing, and the responsible conduct of research.

Until March 2011 she was a policy analyst at the J. Craig Venter Institute. Her research focused on identifying emerging societal concerns associated with emerging genomic technologies.

Michele graduated in Genetics from the University of California, Berkeley and obtained her Ph.D. in Microbiology from the University of Washington, Seattle. She also holds an M.A. in Science, Technology, and Public Policy from the George Washington University. She was a post-doctoral fellow at the Fred Hutchinson Cancer Research Center in Seattle and a research fellow at Columbia University.